283 related articles for article (PubMed ID: 32200762)
1. Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop.
Wu YW; Huang CC; Changou CA; Lu LS; Goubran H; Burnouf T
J Biomed Sci; 2020 Mar; 27(1):45. PubMed ID: 32200762
[TBL] [Abstract][Full Text] [Related]
2. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
[TBL] [Abstract][Full Text] [Related]
3. The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles.
Johnson L; Coorey CP; Marks DC
Transfusion; 2014 Aug; 54(8):1917-26. PubMed ID: 24527873
[TBL] [Abstract][Full Text] [Related]
4. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: effect of agonists, pH, and plasma and saline resuspension.
Valeri CR; Macgregor H; Ragno G
Transfusion; 2005 Apr; 45(4):596-603. PubMed ID: 15819682
[TBL] [Abstract][Full Text] [Related]
5. Cryopreserved platelets demonstrate reduced activation responses and impaired signaling after agonist stimulation.
Waters L; Padula MP; Marks DC; Johnson L
Transfusion; 2017 Dec; 57(12):2845-2857. PubMed ID: 28905392
[TBL] [Abstract][Full Text] [Related]
6. In vitro comparison of cryopreserved and liquid platelets: potential clinical implications.
Johnson L; Reade MC; Hyland RA; Tan S; Marks DC
Transfusion; 2015 Apr; 55(4):838-47. PubMed ID: 25371169
[TBL] [Abstract][Full Text] [Related]
7. Platelets are highly efficient and efficacious carriers for tumor-targeted nano-drug delivery.
Li QR; Xu HZ; Xiao RC; Liu Y; Tang JM; Li J; Yu TT; Liu B; Li LG; Wang MF; Han N; Xu YH; Wang C; Komatsu N; Zhao L; Peng XC; Li TF; Chen X
Drug Deliv; 2022 Dec; 29(1):937-949. PubMed ID: 35319321
[TBL] [Abstract][Full Text] [Related]
8. Cryopreservation affects platelet macromolecular composition over time after thawing and differently impacts on cancer cells behavior in vitro.
Gavioli G; Razzoli A; Bedolla DE; Di Bartolomeo E; Quartieri E; Iotti B; Berni P; Birarda G; Vaccari L; Schiroli D; Marraccini C; Baricchi R; Merolle L
Platelets; 2023 Dec; 34(1):2281943. PubMed ID: 38010129
[TBL] [Abstract][Full Text] [Related]
9. Cryopreserved buffy-coat-derived platelets reconstituted in platelet additive solution: A safe and available product with sufficient haemostatic effectiveness.
Lejdarova H; Pacasova R; Tesarova L; Koutna I; Polokova N; Michlickova S; Dolecek M
Transfus Apher Sci; 2021 Jun; 60(3):103110. PubMed ID: 33736955
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of platelet fragments and extracellular vesicles produced by apheresis platelets during storage.
De Paoli SH; Patel M; Elhelu OK; Tarandovskiy ID; Tegegn TZ; Simak J
Blood Adv; 2024 Jan; 8(1):207-218. PubMed ID: 37967384
[TBL] [Abstract][Full Text] [Related]
11. Effect of platelet exosomes loaded with doxorubicin as a targeted therapy on triple-negative breast cancer cells.
Uslu D; Abas BI; Demirbolat GM; Cevik O
Mol Divers; 2024 Apr; 28(2):449-460. PubMed ID: 36576666
[TBL] [Abstract][Full Text] [Related]
12. In vitro comparison between gamma-irradiated cryopreserved and Day 7 liquid-stored buffy coat-derived platelet components.
Crimmins D; Flanagan P; Charlewood R; Ruggiero K
Transfusion; 2016 Nov; 56(11):2799-2807. PubMed ID: 27526671
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of cryopreserved autologous platelet concentrates in HLA-alloimmunized patients with hematologic malignancies.
Gerber B; Alberio L; Rochat S; Stenner F; Manz MG; Buser A; Schanz U; Stussi G
Transfusion; 2016 Oct; 56(10):2426-2437. PubMed ID: 27339466
[TBL] [Abstract][Full Text] [Related]
14. pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin.
Du JB; Cheng Y; Teng ZH; Huan ML; Liu M; Cui H; Zhang BL; Zhou SY
Mol Pharm; 2016 May; 13(5):1711-22. PubMed ID: 26998644
[TBL] [Abstract][Full Text] [Related]
15. Cryopreservation of canine platelets.
Appleman EH; Sachais BS; Patel R; Drobatz KJ; Groman RP; Kennedy DR; O'Donnell PA; Bryan C; Callan MB
J Vet Intern Med; 2009; 23(1):138-45. PubMed ID: 19175732
[TBL] [Abstract][Full Text] [Related]
16. Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma
Patras L; Ionescu AE; Munteanu C; Hajdu R; Kosa A; Porfire A; Licarete E; Rauca VF; Sesarman A; Luput L; Bulzu P; Chiroi P; Tranca RA; Meszaros MS; Negrea G; Barbu-Tudoran L; Potara M; Szedlacsek S; Banciu M
Cancer Biol Ther; 2022 Dec; 23(1):1-16. PubMed ID: 34964693
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived- Extracellular Vesicles Promote Hemostasis and Prevent the Development of Hemorrhagic Shock.
Lopez E; Srivastava AK; Burchfield J; Wang YW; Cardenas JC; Togarrati PP; Miyazawa B; Gonzalez E; Holcomb JB; Pati S; Wade CE
Sci Rep; 2019 Nov; 9(1):17676. PubMed ID: 31776369
[TBL] [Abstract][Full Text] [Related]
18. Dual stimuli polysaccharide nanovesicles for conjugated and physically loaded doxorubicin delivery in breast cancer cells.
Pramod PS; Shah R; Jayakannan M
Nanoscale; 2015 Apr; 7(15):6636-52. PubMed ID: 25797322
[TBL] [Abstract][Full Text] [Related]
19. Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets.
Pienimaeki-Roemer A; Kuhlmann K; Böttcher A; Konovalova T; Black A; Orsó E; Liebisch G; Ahrens M; Eisenacher M; Meyer HE; Schmitz G
Transfusion; 2015 Mar; 55(3):507-21. PubMed ID: 25332113
[TBL] [Abstract][Full Text] [Related]
20. Engineered Platelet-Based Micro/Nanomotors for Cancer Therapy.
Li T; Chen T; Chen H; Wang Q; Liu Z; Fang L; Wan M; Mao C; Shen J
Small; 2021 Dec; 17(52):e2104912. PubMed ID: 34741421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
